Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

After pulling back sharply from its 52-week high, Rocket Lab (NASDAQ: RKLB) appears to be carving out a meaningful support zone.

Shares are down nearly 30% from their record highs, pressured by February’s broader risk-off rotation in growth stocks and lingering concerns tied to a Neutron development setback earlier this year. Sentiment shifted quickly when the company disclosed a Stage 1 tank rupture during routine hydrostatic pressure testing in January, ultimately pushing the timeline for Neutron’s maiden flight further out.

But with earnings now behind it and updated guidance in place, the stock is beginning to stabilize.

If this consolidation ultimately confirms a higher low within its broader uptrend, it could mark the setup that longer-term investors have been waiting for.

Selling Pressure Eases as Support Holds

After weeks of persistent selling, RKLB is showing early signs of stabilization.

Shares remain above the 200-day simple moving average, a key long-term trend indicator. The low $60s have acted as firm support, with buyers stepping in repeatedly at that level. Meanwhile, the 50-day moving average remains overhead as near-term resistance.

If the stock can continue to base constructively and reclaim resistance near the mid-to-high $70s, it would strengthen the case that a higher low is forming within the broader uptrend.

Of course, technical setups must be supported by fundamentals. And in Rocket Lab’s case, the latest earnings report helped reinforce the longer-term growth narrative.

Q4 Earnings Reinforced Growth and Improving Fundamentals

Rocket Lab reported strong Q4 and full-year 2025 results, delivering a revenue and earnings beat while posting record annual sales.

The aerospace company completed 21 successful launches in 2025, including seven in Q4 alone, maintaining a 100% mission success rate for the year. Full-year revenue reached $602 million, up nearly 40% year-over-year. Q4 revenue came in at $180 million, representing 36% growth compared to the prior-year period. GAAP EPS showed a loss of 9 cents, which was slightly better than expectations.

Importantly, the company’s margins continued to improve. GAAP gross margin expanded to 38%, while non-GAAP gross margin reached 44.3%. Adjusted EBITDA loss narrowed meaningfully, reflecting improving operating leverage.

The company ended the year with $1.1 billion in cash and equivalents, providing ample liquidity to fund continued development and expansion. Its backlog climbed to $1.85 billion with management indicating that roughly 37% of that backlog is expected to convert into revenue over the next 12 months.

A major driver of that growth was an $816 million prime contract from the Space Development Agency to build 18 satellites. The Space Systems segment continues to scale alongside launch services, reinforcing the company’s evolution into a more diversified space infrastructure provider. The company also announced several partnerships and acquisitions that further deepen its vertical integration, positioning Rocket Lab as more than just a launch company.

Neutron Timeline Reset

The primary overhang remains: Neutron. Management confirmed that the rocket’s maiden launch is now expected in Q4 2026 following the January test anomaly.

While disappointing for investors hoping for an earlier debut, development risk is inherent in aerospace programs of this scale. Importantly, CFO Adam Spice indicated that Q1 2026 will be Neutron’s peak R&D spending quarter. As development progresses and spending moderates, profitability metrics are expected to improve.

For Q1 2026, management guided revenue between $185 million and $200 million, with GAAP gross margins projected at 34%–36%.

Analysts Remain Supportive

Despite the delay, analyst sentiment remains constructive. Cantor Fitzgerald raised its price target following the earnings release while maintaining an Overweight rating. The firm cited record revenue and strong execution. Needham, however, trimmed its target due to the revised Neutron timeline but still maintained a Buy rating and price target significantly above the consensus.

Overall, RKLB carries a Moderate Buy consensus rating, with institutional flows remaining deeply net positive over the past year.

For now, the chart suggests support is forming, and the fundamentals remain intact. If buyers continue defending key levels and momentum rebuilds, Rocket Lab may be quietly laying the groundwork for its next move higher.

Before you make your next trade, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now…
See The Five Stocks Here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.